Published in Emerg Infect Dis on February 01, 2004
Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence | NCT04448145
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A (2004) 2.38
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol (2005) 1.76
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev (2007) 1.68
Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64
Wrestling SARS from uncertainty. Emerg Infect Dis (2004) 1.50
Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol (2004) 1.42
Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol (2007) 1.09
A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan. BMC Infect Dis (2010) 1.06
Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. J Virol (2005) 1.04
SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos Trans R Soc Lond B Biol Sci (2007) 1.03
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol (2005) 1.03
Confronting SARS: a view from Hong Kong. Philos Trans R Soc Lond B Biol Sci (2004) 0.97
Evaluation of real-time reverse transcriptase PCR and real-time loop-mediated amplification assays for severe acute respiratory syndrome coronavirus detection. J Clin Microbiol (2005) 0.94
Long-term SARS coronavirus excretion from patient cohort, China. Emerg Infect Dis (2004) 0.94
Laboratory diagnosis of SARS. Philos Trans R Soc Lond B Biol Sci (2004) 0.94
Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV). J Pharm Pharm Sci (2008) 0.89
SARS coronavirus detection methods. Emerg Infect Dis (2005) 0.87
Transmission and Control of SARS. Curr Infect Dis Rep (2004) 0.87
Monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay reveals high sensitivity of the nucleocapsid protein in acute-phase sera of severe acute respiratory syndrome patients. Clin Diagn Lab Immunol (2005) 0.85
An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology (2008) 0.84
Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV). Virol J (2007) 0.82
Molecular diagnosis of severe acute respiratory syndrome: the state of the art. J Mol Diagn (2005) 0.82
Intrahost diversity of feline coronavirus: a consensus between the circulating virulent/avirulent strains and the internal mutation hypotheses? ScientificWorldJournal (2013) 0.81
Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin Vaccine Immunol (2007) 0.80
SARS transmission in Vietnam outside of the health-care setting. Epidemiol Infect (2006) 0.80
Features discriminating SARS from other severe viral respiratory tract infections. Eur J Clin Microbiol Infect Dis (2007) 0.79
Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur J Clin Microbiol Infect Dis (2005) 0.79
Detection of severe acute respiratory syndrome coronavirus in stool specimens by commercially available real-time reverse transcriptase PCR assays. J Clin Microbiol (2006) 0.78
Severe acute respiratory syndrome (SARS) in neonates and children. Arch Dis Child Fetal Neonatal Ed (2005) 0.76
Severe acute respiratory syndrome: What have we learned two years later? Can J Infect Dis Med Microbiol (2004) 0.75
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 21.55
Transmission dynamics and control of severe acute respiratory syndrome. Science (2003) 14.70
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet (2003) 13.79
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74
A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 9.22
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin Chem (2003) 4.03
Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol (2003) 2.77
Guideline on management of severe acute respiratory syndrome (SARS). Lancet (2003) 2.71
Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol (2003) 2.05
Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. J Clin Virol (1999) 1.98
Severe acute respiratory syndrome (SARS): over 100 days into the outbreak. Wkly Epidemiol Rec (2003) 0.83
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med (2005) 15.53
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet (2003) 13.79
A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 9.22
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol (2003) 9.09
The severe acute respiratory syndrome. N Engl J Med (2003) 7.48
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 5.40
Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet (2004) 5.32
Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol (2004) 5.17
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol (2004) 5.08
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04
Lung pathology of fatal severe acute respiratory syndrome. Lancet (2003) 5.02
Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A (2009) 4.36
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol (2009) 4.10
Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin Chem (2003) 4.03
Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem (2005) 3.75
Gain-of-function experiments on H7N9. Science (2013) 3.67
Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis (2003) 3.66
MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis (2014) 3.64
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
H5N1 outbreaks and enzootic influenza. Emerg Infect Dis (2006) 3.49
Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis (2013) 3.35
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J (2005) 3.14
Influenza-associated hospitalization in a subtropical city. PLoS Med (2006) 3.07
Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J Virol (2002) 2.97
Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet (2003) 2.84
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis (2006) 2.76
Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol (2005) 2.56
Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med (2007) 2.53
Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51
MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis (2014) 2.47
Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res (2007) 2.45
Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis (2005) 2.43
Long-term evolution and transmission dynamics of swine influenza A virus. Nature (2011) 2.39
Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology (2003) 2.36
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
Influenza: emergence and control. J Virol (2004) 2.31
Pause on avian flu transmission research. Science (2012) 2.24
Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog (2008) 2.14
Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis (2009) 2.13
Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol (2010) 2.11
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Temporally structured metapopulation dynamics and persistence of influenza A H3N2 virus in humans. Proc Natl Acad Sci U S A (2011) 2.06
Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol (2003) 2.05
Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A (2011) 2.04
Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis (2005) 2.03
Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax (2006) 1.95
Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol (2005) 1.93
Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis (2003) 1.93
Effect of interventions on influenza A (H9N2) isolation in Hong Kong's live poultry markets, 1999-2005. Emerg Infect Dis (2007) 1.82
Risk for infection with highly pathogenic influenza A virus (H5N1) in chickens, Hong Kong, 2002. Emerg Infect Dis (2007) 1.79
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol (2005) 1.76
Avian coronavirus in wild aquatic birds. J Virol (2011) 1.73
Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol (2004) 1.72
Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol (2010) 1.71
Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol (2010) 1.67
Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J Immunol (2009) 1.66
Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol (2007) 1.65
H5N1 influenza viruses in Lao People's Democratic Republic. Emerg Infect Dis (2006) 1.64
Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001. J Virol (2003) 1.62
Characterization of avian influenza viruses A (H5N1) from wild birds, Hong Kong, 2004-2008. Emerg Infect Dis (2009) 1.61
Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg Infect Dis (2008) 1.59
Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis". Science (2012) 1.58
Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol (2004) 1.56
Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis (2004) 1.55
Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem (2004) 1.55
Gene flow and competitive exclusion of avian influenza A virus in natural reservoir hosts. Virology (2009) 1.54
Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol (2008) 1.53
Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest (2004) 1.51
Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio (2013) 1.49
Detection of diverse astroviruses from bats in China. J Gen Virol (2009) 1.46
Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis (2008) 1.46
Poultry drinking water used for avian influenza surveillance. Emerg Infect Dis (2007) 1.45
Genotypic diversity of H5N1 highly pathogenic avian influenza viruses. J Gen Virol (2008) 1.43
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine (2005) 1.42
Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. J Infect Dis (2009) 1.41
Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol (2014) 1.39
Multiannual patterns of influenza A transmission in Chinese live bird market systems. Influenza Other Respir Viruses (2012) 1.38
Detection and phylogenetic analysis of group 1 coronaviruses in South American bats. Emerg Infect Dis (2008) 1.38
Avian influenza and ban on overnight poultry storage in live poultry markets, Hong Kong. Emerg Infect Dis (2012) 1.38
Detection of human influenza A viruses by loop-mediated isothermal amplification. J Clin Microbiol (2005) 1.37
Novel reassortment of Eurasian avian-like and pandemic/2009 influenza viruses in swine: infectious potential for humans. J Virol (2011) 1.33
Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol (2009) 1.33
Role of terrestrial wild birds in ecology of influenza A virus (H5N1). Emerg Infect Dis (2007) 1.33
EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer (2003) 1.32
Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology (2010) 1.32
Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog (2012) 1.32
Establishment and lineage replacement of H6 influenza viruses in domestic ducks in southern China. J Virol (2012) 1.32